MetaCap

Redhill Biopharma (RDHL) News

NASDAQ: RDHLHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.281-0.0423 (-13.08%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

RDHL news summary

We found 1 recent headline mentioning Redhill Biopharma (RDHL): 1 in the past week and 1 in the past 30 days, most often from PR Newswire. RDHL is making an outsized move today, down 13.08% at $0.281, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "RedHill Biopharma (Nasdaq: RDHL) Highlights Strategic Transformation and Expanded Commercial Growth Strategy in Virtual Investor "What This Means" Segment", was published by PR Newswire on Nov 17, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Redhill Biopharma headlines

Compare RDHL